Results 41 to 50 of about 31,515 (266)

Antifungal Prophylaxis in Solid Organ Transplant Recipients [PDF]

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2015
Solid organ transplantation (SOT) is a treatment method that improves quality of life and survival of patients with end-stage organ failure. Immunosuppressive treatments given to these patients may predispose to the development of invasive fungal ...
Şebnem ŞENOL   +18 more
doaj   +1 more source

The Surgical Infection Society revised guidelines on the management of intra-abdominal infection [PDF]

open access: yes, 2017
Background: Previous evidence-based guidelines on the management of intra-abdominal infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and 2010. At the time the most recent guideline was released, the plan was to update
Chang, Phillip K   +11 more
core   +3 more sources

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. [PDF]

open access: yes, 2017
Purpose of reviewDiagnosis during early stages of invasive aspergillosis (IA) and targeted antifungal treatment has the potential to improve survival significantly.
Heldt, Sven, Hoenigl, Martin
core   +1 more source

Fluconazole prophylaxis in preterm infants: a systematic review

open access: yesBrazilian Journal of Infectious Diseases, 2017
Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.
Juliana Ferreira da Silva Rios   +3 more
doaj   +1 more source

Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria? [PDF]

open access: yes, 2016
The definition of pulmonary fungal infections (PFI) according to the EORTC-MSG criteria may lack diagnostic sensitivity due to the possible presentation of PFI with different radiological pictures.
Ascioglu   +19 more
core   +1 more source

Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies:reviewing the available evidence [PDF]

open access: yes, 2011
There has been a large increase in the incidence of invasive fungal infections (IFIs) over the past decades, largely because of the increasing size of the population at risk.
Daenen, Simon M. G. J.   +3 more
core   +10 more sources

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2017
Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications ...
Mayur D. Mody MD   +3 more
doaj   +1 more source

Advances in the Treatment of Mycoses in Pediatric Patients

open access: yesJournal of Fungi, 2018
The main indications for antifungal drug administration in pediatrics are reviewed as well as an update of the data of antifungal agents and antifungal policies performed.
Elias Iosifidis   +2 more
doaj   +1 more source

Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics [PDF]

open access: yes, 2006
When critically ill patients with pancreatitis develop infection of the pancreas, the ongoing management of such patients becomes difficult. Sufficient evidence supports the use of broad-spectrum antibiotic prophylaxis to prevent the development of ...
Eggimann, P.   +2 more
core   +2 more sources

The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study

open access: yesTurkish Journal of Hematology, 2018
Objective: Invasive fungal infections (IFIs) are a significant cause of morbidity and mortality among neutropenic patients undergoing chemotherapy for acute myeloid leukemia (AML) and stem cell transplantation.
Vildan Özkocaman   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy